Vyondys 53 FDA Approval History
FDA Approved: Yes (First approved December 12, 2019)
Brand name: Vyondys 53
Generic name: golodirsen
Dosage form: Injection
Company: Sarepta Therapeutics
Treatment for: Duchenne Muscular Dystrophy
Vyondys 53 (golodirsen) is a phosphordiamidate morpholino oligimer for the treatment of Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation amenable to exon 53 skipping.
Development Timeline for Vyondys 53
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.